181
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Retrospective Comparison of Ahmed Glaucoma Valve Implants with or without Ologen Collagen Matrix

ORCID Icon, , , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 15-23 | Received 11 Nov 2022, Accepted 29 Dec 2022, Published online: 04 Jan 2023

References

  • Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224
  • Sihota R, Angmo D, Ramaswamy D, Dada T. Simplifying “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66(4):495–505. doi:10.4103/ijo.IJO_1130_17
  • Crawley L, Zamir SM, Cordeiro MF, Guo L. Clinical options for the reduction of elevated intraocular pressure. Ophthalmol Eye Dis. 2012;4:43–64. doi:10.4137/OED.S4909
  • Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995;120(1):23–31. doi:10.1016/S0002-9394(14)73755-9
  • Christakis PG, Kalenak JW, Zurakowski D, et al. The Ahmed versus Baerveldt study: one-year treatment outcomes. Ophthalmology. 2011;118(11):2180–2189. doi:10.1016/j.ophtha.2011.05.004
  • Budenz DL, Feuer WJ, Barton K, et al.; Ahmed Baerveldt Comparison Study Group. Postoperative complications in the Ahmed Baerveldt Comparison Study during five years of follow-up. Am J Ophthalmol. 2016;163:75–82.e3. doi:10.1016/j.ajo.2015.11.023
  • Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers. 2002;33(2):94–101. doi:10.3928/1542-8877-20020301-04
  • Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome. Ophthalmology. 2003;110(9):1814–1821. doi:10.1016/S0161-6420(03)00574-8
  • Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve. Am J Ophthalmol. 2003;136:1001–1008. doi:10.1016/S0002-9394(03)00630-5
  • Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105:1968–1976. doi:10.1016/S0161-6420(98)91049-1
  • Hsu WC, Spilker MH, Yannas IV, Rubin PAD. Inhibition of conjunctival scarring and contraction by a porous collagen-glycosaminoglycan implant. Invest Ophthalmol Vis Sci. 2000;41(9):2404–2411.
  • Yuan F, Li L, Chen X, Yan X, Wang L. Biodegradable 3D-porous collagen matrix (Ologen) compared with mitomycin C for treatment of primary open-angle glaucoma: results at 5 years. J Ophthalmol. 2015;2015:637537. doi:10.1155/2015/637537
  • Chen HS, Ritch R, Krupin T, Hsu WC. Control of filtering bleb structure through tissue bioengineering: an animal model. Invest Ophthalmol Vis Sci. 2007;48(2):485.
  • Huang MC, Netland PA, Coleman AL, et al. Intermediate-term clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;127(1):27–33. doi:10.1016/S0002-9394(98)00394-8
  • Lai JS, Poon AS, Chua JK, et al. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol. 2000;84(7):718–721. doi:10.1136/bjo.84.7.718
  • Coleman AL, Smyth RJ, Wilson MR, Tam M. Initial clinical experience with the Ahmed Glaucoma Valve implant in pediatric patients. Arch Ophthalmol. 1997;115(2):186–191. doi:10.1001/archopht.1997.01100150188007
  • Rho S, Sung Y, Ma KT, Rho SH, Kim CY. Bleb analysis and short-term results of biodegradable collagen matrix-augmented Ahmed glaucoma valve implantation: 6-month follow-up. Invest Ophthalmol Vis Sci. 2015;56(10):5896–5903. doi:10.1167/iovs.15-17480
  • Kim TJ, Kang S, Jeoung JW, Kim YK, Park KH. Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant. BMC Ophthalmol. 2018;18(1):45. doi:10.1186/s12886-018-0709-2
  • Song M, Lee S, Choe D, Kim S, Roh YH, Rho S. Clinical and biological evaluations of biodegradable collagen matrices for glaucoma drainage device implantation. Invest Ophthalmol Vis Sci. 2017;58(12):5329–5335. doi:10.1167/iovs.17-22579
  • Sastre-Ibáñez M, Cabarga C, Canut MI, et al. Efficacy of Ologen matrix implant in Ahmed glaucoma valve implantation. Sci Rep. 2019;9:3178. doi:10.1038/s41598-019-38656-x
  • Harizman N, Du J, Tai TY. A prospective randomized trial of Ahmed glaucoma drainage device implantation with or without Ologen collagen matrix. Ophthalmol Glaucoma. 2021;4(4):421–426. doi:10.1016/j.ogla.2020.12.005